share_log

Have Tevogen Bio Holdings Insiders Been Selling Stock?

Have Tevogen Bio Holdings Insiders Been Selling Stock?

Tevogen Bio Holdings內部人士一直在出售股票嗎?
Simply Wall St ·  10/20 20:59

We wouldn't blame Tevogen Bio Holdings Inc. (NASDAQ:TVGN) shareholders if they were a little worried about the fact that Neal Flomenberg, the Chief Scientific Officer and Global R&D Lead recently netted about US$1.7m selling shares at an average price of US$1.62. That sale reduced their total holding by 20% which is hardly insignificant, but far from the worst we've seen.

如果Tevogen Bio Holdings Inc. (納斯達克:TVGN) 的股東對首席科學官兼全球研發總監Neal Flomenberg最近以平均價格爲1.62美元出售股票,淨賺約170萬美元一事感到有些擔憂,那也是可以理解的。這次出售減少了他們的總持股量20%,雖然並不算微不足道,但也遠非我們見過的最糟糕的情況。

Tevogen Bio Holdings Insider Transactions Over The Last Year

過去一年的Tevogen Bio Holdings內部交易情況

Notably, that recent sale by Neal Flomenberg is the biggest insider sale of Tevogen Bio Holdings shares that we've seen in the last year. That means that even when the share price was below the current price of US$1.72, an insider wanted to cash in some shares. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. This single sale was just 20% of Neal Flomenberg's stake.

值得注意的是,Neal Flomenberg最近的這筆交易是我們在過去一年裏看到的Tevogen Bio Holdings股票中最大的內部人士交易。這意味着即使當股價低於當前的1.72美元時,一名內部人員還是希望套現一些股票。當一名內部人員低於當前價格賣出時,表明他們認爲較低價格是公平的。這讓我們想知道他們對(更高)最近的估值持何看法。儘管內部賣出並不是一個積極的信號,但我們不能確定這是否意味着內部人員認爲股票已經充分價值,因此這只是一個不太明確的信號。這一次的交易只佔了Neal Flomenberg持股的20%。

Happily, we note that in the last year insiders paid US$4.5k for 5.61k shares. On the other hand they divested 1.08m shares, for US$1.7m. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

令人高興的是,我們注意到在過去一年,內部人員以0.45萬美元購買了0.561萬股。另一方面,他們出售了108萬股,共計170萬美元。您可以看到過去一年內部交易(公司和個人)在下面的圖表中呈現。如果您點擊圖表,可以查看所有的單筆交易,包括股價、個人和日期!

big
NasdaqGM:TVGN Insider Trading Volume October 20th 2024
納斯達克 集團管理: TVGN 內部交易量 2024年10月20日

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

如果你喜歡購買內部人員正在購買而不是銷售的股票,那麼你可能會喜歡這份免費的公司列表。(提示:它們中的大部分都被忽視了。)

Does Tevogen Bio Holdings Boast High Insider Ownership?

Tevogen Bio Holdings 是否擁有高比例內部所有權?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. Tevogen Bio Holdings insiders own 92% of the company, currently worth about US$270m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

我喜歡看公司內部人擁有多少股份,以幫助我了解他們與內部人的一致程度。我們通常希望看到相當高比例的內部所有權。Tevogen Bio Holdings 內部人目前擁有公司的92%,根據最近的股價價值約爲27000萬美元。大多數股東會樂見這種內部人持股情況,因爲這表明管理層的激勵與其他股東的利益保持良好一致。

So What Does This Data Suggest About Tevogen Bio Holdings Insiders?

那麼,這些數據對 Tevogen Bio Holdings 內部人有何暗示?

An insider sold Tevogen Bio Holdings shares recently, but they didn't buy any. Zooming out, the longer term picture doesn't give us much comfort. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. In terms of investment risks, we've identified 3 warning signs with Tevogen Bio Holdings and understanding these should be part of your investment process.

最近有內部人 賣出了 Tevogen Bio Holdings 的股票,但他們並未買入任何股票。總體來看,長期情況並未帶來太多安慰。該公司擁有高比例的內部所有權,但鑑於股票銷售歷史,我們還是有些猶豫。雖然了解內部人持股和交易情況很重要,但在做出任何投資決策之前,我們也一定要考慮股票面臨的風險。在投資風險方面,我們已經確定了 Tevogen Bio Holdings 的3個警示信號,了解這些情況應成爲您投資過程的一部分。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

當然,您可能會在其他地方找到一項出色的投資。因此,請查看此免費的有趣公司列表。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論